Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2-Part, Randomized, Double-Blind, Placebo- and Active- Controlled, Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Subjects and Otherwise Healthy Subjects With Primary Insomnia

NCT01463098 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT01463098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01463098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2-Part, Randomized, Double-Blind, Placebo- and Active- Controlled, Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Subjects and Otherwise Healthy Subjects With Primary Insomnia
Lead sponsor
Eisai Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 5, 2011
Completion date
August 11, 2012
Enrollment
122 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia